Muscarinic receptors mediating suppression of Ca+ current and of M-type K+ current in rat superior cervical ganglion neurons were sbclassified ph ically by using the muscarinic receptor antagonists pirenzepine and himbacine. Our voltage clamp experiments previously distinguished fast and slow intraceliular signaling pathways coupling muscarinic receptors to calcium channels. We now establish that the fast, pertussis toxin-sensitive suppression of Ca+ current is mediated primarily by muscarinic receptors of the M4 subtype, whereas the slow, bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetate (BAPTA)-sensitive suppression of Ca2+ current is mediated primarily by muscarinic receptors of the Ml subtype. Both actions on Ca2+ current are blocked by guanosine 5'-[13-thio]diphosphate. Muscarnic suppression of M current is slow, BAPTA-sensitive, and mediated by receptors of the Ml subtype. Hence the two musarinic pathways use different receptors and different guanine nucleotide binding proteins to produce different actions on channels.
pression of Ich, and a slow BAPTA-sensitive suppression of IM. This paper investigates whether all these actions are mediated by the same muscarinic receptors. The existence of different subtypes of muscarinic receptors, first suggested by Barlow et al. (14) using 4-diphenylacetoxy-N-methylpiperidine, was established by Hammer et al. (15) in binding studies using the muscarinic receptor antagonist pirenzepine. Five muscarinic receptor subtypes have now been cloned (16) and affinity profiles for numerous semispecific antagonists have been determined (17, 18) , providing effective tools for pharmacological subclassification of muscarinic effects. A primary role for M1 receptors in inhibiting IM was suggested by Marrion et al. (19) using pirenzepine and AF-DX 116 in work done before the discovery of all five muscarinic receptor subtypes. We confirm their conclusion and show here that Ml and M4 receptors are involved in the modulation of 'Ca.
MATERIALS AND METHODS
Cell Preparation and Current Recording. Neurons were dissociated from the SCG of 5-to 6-week-old male SpragueDawley rats (3, 4) . They were either kept at 40C and studied within 10 hr or plated on collagen-coated plastic dishes and incubated up to 30 hr in culture medium at 370C. Currents were recorded in the whole-cell configuration of the patchclamp technique (20) at 200C-230C (pipette resistances, 1-2 MU), low-pass filtered at 1 kHz, and sampled at 2 kHz. Potentials have been corrected for junction potentials of -2 mV (0.1 mM BAPTA) or -4 mV (20 mM BAPTA). To study ICa, we used Cs-based pipette solutions. The membrane potential was held at -80 mV and stepped every 4 s to -40 mV for 2.5 ms to reduce capacity transients (4) and then to 0 mV for 10 ms. Peak ICa was measured as the peak current during the step to 0 mV minus the current recorded after addition of 100 uM Cd2+ to the bath to block Ca channels. To study IM, we used a KCl-based pipette solution, held the membrane potential at -25 mV, where IM is activated, and stepped every 5 s to -55 mV for 500 ms to close M channels. Means are given with SEM in the text and figures.
PTX and BAPTA Treatments. For PTX experiments, we left neurons 22-30 hr in culture medium with PTX (50 ng/ml) at 370C (5) . To load neurons with the Ca chelator BAPTA, we used Cs-based 20 mM BAPTA. Mean series resistance and cell capacitance of acutely dissociated neurons loaded with BAPTA were 4.3 + 0.1 MU and 31 ± 2 pF (n = 69).
Whole-cell dialysis for at least 5 min was allowed before drug application. We estimate that after 5 min of dialysis neurons may have contained -11 mM BAPTA (3). In six neurons treated with PTX and then loaded with high BAPTA, mean series resistance and cell capacitance were 4.0 ± 0.6 MU and Proc. Natl. Acad. Sci. USA 89 (1992) 9545 69 ± 7 pF. In these neurons, 12 min of dialysis was allowed because cells are larger after 1 day of culture (3) .
Schild Plots. Antagonist affinities were analyzed by the method of Arunlakshana and Schild (21) . Antagonists were perfused in the bath for at least 5 min before testing with the muscarinic agonist, oxotremorine methiodide (oxo-M). Dose ratios are ratios of oxo-M concentrations that elicit an equal suppression of ICa or IM in the presence or absence of antagonist. To calculate dose ratios, concentrations ofoxo-M giving a certain percentage inhibition of current (e.g., 25% in Fig. 3B ) were obtained from Hill equations fitted to the control mean data points. In the presence of antagonist, the concentration of oxo-M required to produce the same percentage inhibition in each cell was obtained by interpolation from the closest two data points. They were calculated for each individual cell, plotted as a Schild plot, and unconstrained or constrained-unity slope lines were fitted using the simplex algorithm (22) . Intercepts of these lines yield empirical measures of antagonist affinities, pA2 and pKB, as described and defined by Jenkinson (23) , which can be compared to published affinities pKB estimated from binding and functional studies in the literature. Confidence limits (95%) were calculated as described by Goldstein (24) .
Materials and Solutions. Chemical sources and solutions were as described (5) 
RESULTS
Muscarinic Suppression ofIca and IM. Application ofoxo-M at increasing concentrations produces an increasing inhibition of ICa and IM. Modulatory Pathways. Intracellular BAPTA and treatments with PTX can be used to distinguish two parallel signaling pathways coupling muscarinic receptors and Ca channels (4, 5) . Thus, loading with BAPTA or treating with PTX attenuates the muscarinic response only partially (Fig.   2A) ; the mean suppression ofICa by 10 jLM oxo-M in control, BAPTA-loaded, and PTX-treated cells is 84% + 2%, 47% ± 31%, and 58% + 4%, respectively. But when both treatments are used simultaneously ( Fig. 2A) , muscarinic modulation is almost abolished (suppression of only 5% ± 2%), suggesting that the coupling between muscarinic receptors and Ca channels is primarily BAPTA sensitive or PIX sensitive. Only one pathway is PTX sensitive, but both seem to involve GTP-binding regulatory proteins (G proteins), as muscarinic modulation is virtually abolished (suppression of 7% ± 3%) in cells dialyzed with 1 mM GDP[I8S]. Fig. 2B (curve mul.) shows a predicted doseresponse relation for the control condition, assuming that the individual BAPTA-sensitive and PTX-sensitive actions combine multiplicatively-i.e., that each acts independently to diminish the effective conductance of the same pool of channels (5) . Surprisingly, this prediction underestimates the actual extent of suppression at low and middle oxo-M concentrations, suggesting a positive cooperativity between the two pathways. antagonist, had an EC50 of 1.2 ,uM and a maximum inhibition of 52%. This line is the same as that drawn in Fig. 2 . The oxo-M dose-response curves were shifted rightward by pirenzepine (Fig. 3A Left) and by himbacine (Fig. 3B Left) . A Schild plot for the pirenzepine data (see Materials and Methods) is shown in Fig. 3A (Right) . An unconstrained fit of the slope (continuous line) yielded a pA2 value of 8.1 (95% confidence limits, 7.6-9.0; n = 20) and a constrained unity slope (dashed line) yielded an estimated pKB value of 8.0.
According to published estimates of pirenzepine affinities in various mammalian cells (Fig. 4 ) , our results suggest that M1 or M4 or both receptor subtypes mediate the inhibition. In COS-7 cells, expressed ml and m4 receptors have a similar high affinity for pirenzepine (29) . (We follow convention here in using a lowercase m to designate subtypes identified through sequences and a capital M to designate subtypes distinguished by pharmacology.) The relative scatter of our observations (pA2 value, 7.6-9.0) does not allow discrimination between M1 and M4 receptors but indicates little involvement of the other receptor subtypes. Himbacine (30) is currently the best antagonist to distinguish between M1 and M4 receptor subtypes. (n = 7), and 10 ,uM (n = 7) himbacine (him) and corresponding Schild plot. Dose ratios were calculated for 25% inhibition of ICa and slope of the unconstrained fitted line is 0. (4, 13) , sensitive to intracellular BAPTA (3), and uses a PTX-insensitive G protein (12, 34) . Similarly, one pathway coupling muscarinic receptors to suppression of both N-and L-type Ca channels is slow, sensitive to intracellular BAPTA, and insensitive to PTX (3) (4) (5) 8) . Another pathway, acting only on N-type Ca channels, is faster, insensitive to intracellular BAPTA, and abolished by PTX (1, (3) (4) (5) 8) .
The cDNAs encoding five different muscarinic receptor subtypes have been identified (29, (35) (36) (37) . In general, m1, M3, Shift of oxo-M dose-response curve by 10 nM (n = 6), 100 nM (n = 6), and 1 ,uM (n = 7) pirenzepine (pz) and corresponding Schild plot. Dose ratios were calculated for 50% inhibition of IM and slope of the unconstrained fitted line is 0.8. (B) Shift of oxo-M dose-response curve by 100 nM (n = 7), 1 A&M (n = 7), and 10 A&M (n = 6) himbacine (him) and corresponding Schild plot. Dose ratios were calculated for 50%o inhibition of IM and slope of the unconstrained fitted line is 0.8. and m5 code for receptors regulating inositol phospholipid hydrolysis through a PTX-insensitive G protein, whereas m2 and m4 code for those linked to adenylyl cyclase inhibition through a PTX-sensitive G protein (16, 38, 39 (Fig. 3A) . Here, at the highest concentration (1 ,uM) (41) and m2 receptor subtype proteins are present in rabbit sympathetic ganglia (40) . Possibly this discrepancy reflects species differences, as we do not know which receptors are expressed at the protein level in the rat SCG. Alternatively, functional m2 receptor subtypes may not be present in all SCG neurons and the dissociation procedure may select a population of neurons without them. A third possibility would be that enzyme treatment during the dissociation procedure has damaged m2 receptors. There is another suggestion of functional M4 receptors in sympathetic neurons. Eltze (42) studied the antagonist affinities of muscarinic receptors mediating a presynaptic inhibition of sympathetic nerve action on rabbit vas deferens, finding a moderate to high affinity for pirenzepine and a high affinity for himbacine. Although Eltze originally concluded that the receptors have the M1 subtype, newer work would suggest that this profile is that of an M4 receptor (28) . Our assignment of M1 receptors to inhibition of IM agrees with other evidence. In transfected NG108-15 cells, activation of either ml or m3 receptors inhibits IM-the inhibition with m3 receptors was full versus 50% with ml (43) . The inhibition was mediated by a PTX-insensitive G protein, as in sympathetic neurons. No inhibition was seen in m2-or m4-transfected cells or in control NG108-15 cells, which have endogenous M4 receptors. At least in the rabbit, SCG neurons do not seem to express m3 receptors (40) . In rat, we find that stimulation of M1 receptors suppresses IM by -900%.
What physiological roles can be attributed to these Ml and M4 receptors? N-type Ca channels seem to play a major role in the release of norepinephrine by sympathetic neurons (44) , and trans-synaptic inhibition of norepinephrine secretion by acetylcholine released from parasympathetic fibers has been suggested (45) . It is possible that this inhibitory mechanism at nerve terminals is activated by M4 receptors, which couple solely to N-type Ca channels (this study and ref. 8); however, the relative abundance of the various muscarinic receptor subtypes at sympathetic nerve terminals remains unknown. On the other hand, M1 and M4 receptors, both said to be present on the cell body, should be able to affect cell excitability, calcium-dependent enzyme activity, or gene expression (46) . Activation of M1 receptors, which inhibit three different channel types through a slow process involving a diffusible second messenger, may affect neuronal excitability more profoundly than activation ofthe M4 receptors directed only toward N-type Ca channels.
